Know what you really own

Unwrap both →

Fund comparison · from official SEC filings

IDNA vs LABU: how much do they overlap?

iShares Genomics Immunology and Healthcare ETF and Direxion Daily S&P Biotech Bull 3X Shares

Fund A

vs

Fund B

Holdings overlap

12%

of assets, by weight

Shared positions

25

of 62 / 154 holdings

IDNA expense ratio

0.47%

net, per year

LABU expense ratio

0.93%

net, per year

Shared holdings

Company

IDNA

LABU

R

RVMDREVOLUTION MEDICINES INC

5.70%

1.27%

M

MRNAMODERNA INC

5.22%

0.72%

E

EXELEXELIXIS INC

3.16%

0.94%

T

TWSTTWIST BIOSCIENCE CORP

3.15%

1.10%

R

REGNREGENERON PHARMACEUTICALS

3.10%

0.80%

V

VRTXVERTEX PHARMACEUTICALS INC

2.96%

0.76%

I

INCYINCYTE CORP

2.93%

0.89%

I

IDYAIDEAYA BIOSCIENCES INC

2.25%

0.49%

I

IBRXIMMUNITYBIO INC

2.17%

0.76%

R

RCUSARCUS BIOSCIENCES INC

1.77%

0.57%

C

CRSPCRISPR THERAPEUTICS AG

1.50%

0.92%

N

NVAXNOVAVAX INC

1.09%

0.38%

I

IOVAIOVANCE BIOTHERAPEUTICS INC

1.03%

0.28%

V

VIRVIR BIOTECHNOLOGY INC

0.89%

0.27%

C

CRVSCORVUS PHARMACEUTICALS INC

0.80%

0.33%

J

JANXJANUX THERAPEUTICS INC

0.71%

0.21%

K

KURAKURA ONCOLOGY INC

0.69%

0.23%

N

NTLAINTELLIA THERAPEUTICS INC

0.47%

0.53%

C

CTMXCYTOMX THERAPEUTICS INC

0.50%

0.20%

O

OCGNOCUGEN INC

0.49%

0.10%

R

RIGLRIGEL PHARMACEUTICALS INC

0.47%

0.21%

V

VSTMVERASTEM INC

0.33%

0.12%

X

XNCRXENCOR INC

0.25%

0.18%

P

PRMEPRIME MEDICINE INC

0.10%

0.15%

O

OABIOMNIAB INC

0.00%

0.00%

Only in IDNA

B

BISXXBCF INSTITUTIONAL-SL AGNCY

17.45%

I

IPSEFIPSEN

4.36%

B

BAYZFBAYER AG-REG

3.64%

T

TKPHFTAKEDA PHARMACEUTICAL CO LTD

3.51%

M

MRKMERCK & CO. INC.

3.45%

G

GLAXFGSK PLC

3.43%

B

BNTXBIONTECH SE-ADR

3.39%

R

RHHVFROCHE HOLDING AG

3.32%

S

SNYNFSANOFI

2.98%

G

GNMSFGENMAB A/S

2.63%

C

CAICARIS LIFE SCIENCES INC

2.03%

O

OPHLFONO PHARMACEUTICAL CO LTD

1.55%

2

2595GENFLEET THERAPEUTICS SHAN-H

1.00%

N

NUVBNUVATION BIO INC

0.98%

A

ABCLABCELLERA BIOLOGICS INC

0.88%

6

6887SUNSHINE LAKE PHARMA CO LT-H

0.52%

1

174900ABCLON INC

0.47%

S

SGBCFSHANGHAI HENLIUS BIOTECH I-H

0.42%

P

PACBPACIFIC BIOSCIENCES OF CALIF

0.40%

D

DSGNDESIGN THERAPEUTICS INC

0.39%

I

INRLFVALNEVA SE

0.37%

D

DNAGINKGO BIOWORKS HOLDINGS INC

0.33%

A

ALVOALVOTECH SA

0.33%

P

PSNLPERSONALIS INC

0.27%

2

2591GUANGZHOU INNOGEN PHARMACE-H

0.11%

Only in LABU

?

—DREYFUS GOVERNMENT CASH MANAGE

7.43%

?

—N/A

7.26%

?

—GOLDMAN FINANCIAL

6.27%

?

—GOLDMAN SACHS LIQ ES FD A

1.71%

1

1JKAPELLIS PHARMACEUTICALS INC

1.44%

T

TVTXTRAVERE THERAPEUTICS INC

1.25%

A

ARWRARROWHEAD PHARMACEUTICALS IN

1.11%

S

SMMTSUMMIT THERAPEUTICS INC

1.09%

A

ALKSALKERMES PLC

1.07%

T

TGTXTG THERAPEUTICS INC

1.06%

M

MDGLMADRIGAL PHARMACEUTICALS INC

1.06%

B

BEAMBEAM THERAPEUTICS INC

1.02%

A

APGEAPOGEE THERAPEUTICS INC

0.98%

S

SRRKSCHOLAR ROCK HOLDING CORP

0.95%

P

PRAXPRAXIS PRECISION MEDICINES I

0.95%

M

MIRMMIRUM PHARMACEUTICALS INC

0.93%

U

UTHRUNITED THERAPEUTICS CORP

0.92%

N

NTRANATERA INC

0.92%

C

CELCCELCUITY INC

0.92%

K

KRYSKRYSTAL BIOTECH INC

0.91%

P

PTGXPROTAGONIST THERAPEUTICS INC

0.90%

N

NBIXNEUROCRINE BIOSCIENCES INC

0.89%

C

CGONCG ONCOLOGY INC

0.89%

C

CYTKCYTOKINETICS INC

0.89%

?

—Nuvalent Inc

0.88%

Hold IDNA and LABU together? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Other comparisons you might like

LABU vs BIPIXBIOTECHNOLOGY ULTRASECTOR PROFUND

LABU vs XBIState Street(R) SPDR(R) S&P(R) Biotech ETF

LABU vs BIBProShares Ultra Nasdaq Biotechnology

LABU vs IBBQInvesco Nasdaq Biotechnology ETF

LABU vs IBBiShares Biotechnology ETF

IDNA vs IBBiShares Biotechnology ETF

Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.